The Genital Herpes market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Genital Herpes pipeline products will significantly revolutionize the Genital Herpes market dynamics.
DelveInsight’s “Genital Herpes Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Genital Herpes, historical and forecasted epidemiology as well as the Genital Herpes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Genital Herpes market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Genital Herpes market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Genital Herpes Market Insights
Genital Herpes Overview
Genital Herpes (GH) is a common, sexually transmitted disease caused due to two viruses namely: herpes simplex virus 1 (HSV1) and herpes simplex virus 2 (HSV2). It is characterized by lifelong infection and periodic reactivation with no cure. The virus penetrates in the body through mucous membranes which line the openings of nose, mouth and genitalia. HSV1 and HSV2 are found in body fluids of an infected person.
Some of the key facts of the Genital Herpes Market Report:
- The Genital Herpes market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- Genital Herpes (GH), a common sexually transmitted disease caused due to two viruses namely: herpes simplex virus 1 (HSV1) and herpes simplex virus 2 (HSV2), is characterized by lifelong infection and periodic reactivation with no cure
- According to WHO, an estimated 3.7 billion people under the age of 50, or 67% of the population, had HSV-1 infection (oral or genital)
- Genital herpes infection is common in the United States. According to CDC estimates there were 572,000 new genital herpes infections in the United States
- In May 2021, X-Vax Technology announced that it is preparing to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its experimental vaccine against herpes simplex virus 1 and 2 (HSV-1 and -2)
- Key Genital Herpes Companies: Immune System Regulation, United BioPharma, Heidelberg ImmunoTherapeutics, Genocea Biosciences, AiCuris, Admedus Immunotherapies, Agenus Inc., Sanofi, Rational Vaccines, Starpharma, Brandenburg Antiinfektiva GmbH, JN-International Medical Corporation, BlueWillow Biologics, Vaxxit, Nanoviricides, Vaccibody, Vaxart, Biomere, Immune design (acquired by Merck & Co), AlphaVax, RedBioTec, X-Vax Technology, and others
- Key Genital Herpes Therapies: Acoricus, UB-621, SQX770, and others
- The Genital Herpes epidemiology based on gender analyzed that HSV-2 infection is more common among women than among men. This is possibly because genital infection is more easily transmitted from men to women than from women to men during penile-vaginal sex
Get a Free sample for the Genital Herpes Market Report
Key benefits of the Genital Herpes Market report:
- Genital Herpes market report covers a descriptive overview and comprehensive insight of the Genital Herpes Epidemiology and Genital Herpes market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Genital Herpes market report provides insights on the current and emerging therapies.
- Genital Herpes market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Genital Herpes market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Genital Herpes market.
Download the report to understand which factors are driving Genital Herpes epidemiology trends @ Genital Herpes Epidemiological Insights
Genital Herpes Market
The dynamics of the Genital Herpes market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
“The launch of new products will flourish the Genital Herpes market such as OrganiCare (FemiClear) and Perrigo (Zovirax Cream) announced launch of its new product in 2020. Femiclear is over the counter and used in treatment of genital herpes symptoms and Zovirax contains acyclovir and can be used to reduce further complications in genital herpes.”
Genital Herpes Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Genital Herpes Epidemiology Segmentation:
The Genital Herpes market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Genital Herpes
- Prevalent Cases of Genital Herpes by severity
- Gender-specific Prevalence of Genital Herpes
- Diagnosed Cases of Episodic and Chronic Genital Herpes
Genital Herpes Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Genital Herpes market or expected to get launched during the study period. The analysis covers Genital Herpes market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Genital Herpes Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Genital Herpes market share @ Genital Herpes market forecast
Genital Herpes Therapies and Key Companies
- Acoricus: Pritelivir
- UB-621: United Biopharma
- SQX770: Squarex Pharma
Scope of the Genital Herpes Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Genital Herpes Companies: Immune System Regulation, United BioPharma, Heidelberg ImmunoTherapeutics, Genocea Biosciences, AiCuris, Admedus Immunotherapies, Agenus Inc., Sanofi, Rational Vaccines, Starpharma, Brandenburg Antiinfektiva GmbH, JN-International Medical Corporation, BlueWillow Biologics, Vaxxit, Nanoviricides, Vaccibody, Vaxart, Biomere, Immune design (acquired by Merck & Co), AlphaVax, RedBioTec, X-Vax Technology, and others
- Key Genital Herpes Therapies: Acoricus, UB-621, SQX770, and others
- Genital Herpes Therapeutic Assessment: Genital Herpes current marketed and Genital Herpes emerging therapies
- Genital Herpes Market Dynamics: Genital Herpes market drivers and Genital Herpes market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Genital Herpes Unmet Needs, KOL’s views, Analyst’s views, Genital Herpes Market Access and Reimbursement
Table of Contents
- Genital Herpes Market Report Introduction
- Executive Summary for Genital Herpes
- SWOT analysis of Genital Herpes
- Genital Herpes Patient Share (%) Overview at a Glance
- Genital Herpes Market Overview at a Glance
- Genital Herpes Disease Background and Overview
- Genital Herpes Epidemiology and Patient Population
- Country-Specific Patient Population of Genital Herpes
- Genital Herpes Current Treatment and Medical Practices
- Genital Herpes Unmet Needs
- Genital Herpes Emerging Therapies
- Genital Herpes Market Outlook
- Country-Wise Genital Herpes Market Analysis (2019–2032)
- Genital Herpes Market Access and Reimbursement of Therapies
- Genital Herpes Market Drivers
- Genital Herpes Market Barriers
- Genital Herpes Appendix
- Genital Herpes Report Methodology
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
To know more about Genital Herpes treatment, visit @ Genital Herpes Medications
Related Reports:
Genital Herpes Pipeline
“Genital Herpes Pipeline Insight, 2022” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Genital Herpes market. A detailed picture of the Genital Herpes pipeline landscape is provided, which includes the disease overview and Genital Herpes treatment guidelines.
Genital Herpes Epidemiology
DelveInsight’s ‘Genital Herpes Epidemiology Forecast to 2032‘ report delivers an in-depth understanding of the disease, historical and forecasted Genital Herpes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Other Trending Reports
Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market
Latest Healthcare Blogs
Insights Into The Cutaneous T-cell Lymphoma Treatment Market
Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
Emerging Role of Digital Health in the Field of Oncology
How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com